maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
vimetso 50 mg/850 mg filmsko obložene tablete
metformin; vildagliptin - filmsko obložena tableta - metformin 662,88 mg / 1 tableta vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin
vimetso 50 mg/1000 mg filmsko obložene tablete
metformin; vildagliptin - filmsko obložena tableta - metformin 779,86 mg / 1 tableta vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin
galvus
novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).
betahistin mylan 24 mg tablete
tableta - betahistin
diarönt mono 2.000.000 iu tablete
sanolabor, d.d. - kolistin - tableta - kolistin 2000000 i.e. / 1 tableta - kolistin
eprocliv 50 mg/1000 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin